Skip to content

UroGen Pharma Ltd

US · URGN #2773 by market cap Listed 2017
27.65 -4.08 -12.86%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Recent news

  • Rating change
    Ladenburg Thalmann Initiates UroGen Pharma Ltd(URGN.US) With Buy Rating, Announces Target Price $43
    Market Newswire · 2026/5/11
  • Rating change
    Oppenheimer Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $40
    Market Newswire · 2026/5/19
  • Rating change
    A Quick Look at Today's Ratings for UroGen Pharma Ltd(URGN.US), With a Forecast Between $48 to $75
    Market Newswire · 2026/8/6
  • Rating change
    Urogen Pharma (URGN) Receives a Buy From H.C. Wainwright
    TipRanks · 2026/5/27
  • Rating change
    Goldman Sachs Maintains UroGen Pharma Ltd(URGN.US) With Hold Rating, Raises Target Price to $44
    Market Newswire · 2026/7/16
  • Rating change
    Oppenheimer Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Raises Target Price to $40
    Market Newswire · 2026/5/7
  • Oppenheimer Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $60
    Market Newswire · 2026/10/28
  • Rating change
    Guggenheim Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Raises Target Price to $42
    Market Newswire · 2026/7/22
  • Rating change
    Piper Sandler Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $40
    Market Newswire · 2026/4/20
  • Rating change
    H.C. Wainwright Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $40
    Market Newswire · 2026/4/23
  • Rating change
    Oppenheimer Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Raises Target Price to $60
    Market Newswire · 2026/8/6
  • Rating change
    TD Cowen Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Raises Target Price to $50
    Market Newswire · 2026/7/22
  • Guggenheim Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Cuts Target Price to $56
    Market Newswire · 2026/11/5
  • Rating change
    TD Cowen Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $35
    Market Newswire · 2026/6/16
  • Rating change
    Oppenheimer Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Raises Target Price to $50
    Market Newswire · 2026/7/16
  • A Quick Look at Today's Ratings for UroGen Pharma Ltd(URGN.US), With a Forecast Between $58 to $75
    Market Newswire · 2026/11/6
  • H.C. Wainwright Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $75
    Market Newswire · 2026/11/5
  • Guggenheim Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $58
    Market Newswire · 2026/10/20
  • Rating change
    H.C. Wainwright Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Raises Target Price to $45
    Market Newswire · 2026/5/11
  • Rating change
    H.C. Wainwright Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $45
    Market Newswire · 2026/7/16
  • Rating change
    Piper Sandler Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Raises Target Price to $40
    Market Newswire · 2026/2/13
  • Rating change
    Jefferies Initiates UroGen Pharma Ltd(URGN.US) With Buy Rating, Announces Target Price $40
    Market Newswire · 2026/4/10
  • H.C. Wainwright Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $75
    Market Newswire · 2026/10/20
  • Rating change
    Ladenburg Thalmann Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Raises Target Price to $55
    Market Newswire · 2025/11/8
  • H.C. Wainwright Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $75
    Market Newswire · 2026/8/21

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 20:02:23 · For reference only, not investment advice and not tailored to your situation.

UroGen Pharma Ltd discussion 0 comments

Add a comment